Ranbaxy gets FDA nod to sell antibiotic
The United States Food & Drug Administration (USFDA) has cleared Ranbaxy's request to market an off-patent antibiotic called cefpodoxime proxetil. Cefpodoxime proxetil was researched by Japanese firm
The United States Food & Drug Administration (USFDA) has cleared Ranbaxy's request to market an off-patent antibiotic called cefpodoxime proxetil. Cefpodoxime proxetil was researched by Japanese firm